Typhoid vaccine, inactivated Pregnancy and Breastfeeding Warnings
Brand names: Typhim Vi
Medically reviewed by Drugs.com. Last updated on Jan 3, 2024.
Typhoid vaccine, inactivated Pregnancy Warnings
Use is recommended only if clearly needed and the benefit outweighs the risk.
AU TGA pregnancy category: B2
US FDA pregnancy category: C
Animal studies have not been conducted. There are no controlled data in human pregnancy.
AU TGA pregnancy category B2: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals are inadequate or may be lacking, but available data show no evidence of an increased occurrence of fetal damage.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Typhoid vaccine, inactivated Breastfeeding Warnings
Caution is recommended. Only use in breastfeeding women when there is a high risk of infection.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
See also
References for pregnancy information
- (2022) "Product Information. Typhim VI (typhoid vaccine, inactivated)." Apothecon Inc
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- Cerner Multum, Inc. "Australian Product Information."
References for breastfeeding information
- (2022) "Product Information. Typhim VI (typhoid vaccine, inactivated)." Apothecon Inc
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- Cerner Multum, Inc. "Australian Product Information."
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
